tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Catanzaro, 241 are a BUY (78.76%), 65 are a HOLD (21.24%).
Analyst Joseph Catanzaro, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 43.04% that have a potential upside of 42.74% achieved within 150 days.
Joseph Catanzaro’s has documented 617 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on BMEA, Biomea Fusion at 03-Jun-2025.
Analyst best performing recommendations are on CTMX (CYTOMX THERAPEUTICS).
The best stock recommendation documented was for CTMX (CYTOMX THERAPEUTICS) at 4/14/2025. The price target of $2.5 was fulfilled within 29 days with a profit of $1.89 (309.84%) receiving and performance score of 106.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$1.75
$-0.27 (-13.37%)
$5
10 months 1 days ago
(27-Aug-2024)
1/6 (16.67%)
$0.07 (4.17%)
2
Hold
10 months 7 days ago
(21-Aug-2024)
0/4 (0%)
$31.56 (191.97%)
Buy
1 years 6 months 13 days ago
(15-Dec-2023)
0/1 (0%)
$20.97 (87.27%)
1 years 6 months 13 days ago
(15-Dec-2023)
0/1 (0%)
$93 (163.16%)
1 years 6 months 13 days ago
(15-Dec-2023)
2/2 (100%)
$4.5 (25.00%)
82
Which stock is Joseph Catanzaro is most bullish on?
Which stock is Joseph Catanzaro is most reserved on?
What Year was the first public recommendation made by Joseph Catanzaro?
